Trial Profile
Efficacy and Safety of Ursodesoxycholic Acid in the Management of Non-Alcoholic Steatohepatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 May 2014
Price :
$35
*
At a glance
- Drugs Ursodeoxycholic acid (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Therapeutic Use
- Acronyms URSONASH
- Sponsors Aptalis
- 04 May 2014 New trial record